RenewalBio

Develops embryo-like models to generate transplantable cells

关于 RenewalBio

成立时间2022
RenewalBio is a biotechnology company focused on regenerative medicine. It utilizes its proprietary Stembroid™ platform to reprogram adult cells into induced pluripotent stem cells and guide their differentiation in a three-dimensional environment mimicking early embryonic development, generating transplantable cells and tissues matched to the patient's DNA. The technology aims to address the shortage of organ donors and immune rejection. Current efforts focus on developing hematopoietic stem cells for leukemia and immune disorders, with exploration into liver, heart, and pancreatic cell applications. The company is in the R&D stage, with participation limited to research collaborations and institutional partnerships.
社区
LinkedIn
Website
标签
Medical health

热度值变化趋势

团队成员

Vladik Krupalnik
Vladik Krupalnik

CEO , Co-Founder and Board member

Ohad Gafni
Ohad Gafni

Co-Founder & CSO

投资方

YZi Labs
YZi Labs

投融资详情

--(2025-11-10)
金额:--
投资方:
YZi Labs
YZi Labs
估值:--